Yu et al. [52] revealed that silymarin inhibits HCC cell proliferation under hypoxic conditions by targeting the HIF-1α/VEGF pathway, inducing apoptosis in HepG2 and Hep3B cells. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.